![](/img/cover-not-exists.png)
Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trials
Fujiwara, Yutaka, Kuchiba, Aya, Koyama, Takafumi, Machida, Ryunosuke, Shimomura, Akihiko, Kitano, Shigehisa, Shimizu, Toshio, Yamamoto, NoboruVolume:
5
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2019-000653
Date:
April, 2020
File:
PDF, 467 KB
2020